Innoplexus - a Partex Company
The expert in AI technology for drug discovery and development.
276 employees · est. 2011 · Frankfurt, Germany
Sable Bio
Empowering Discovery: Precision Insights for Safer Drug Targets.
16 employees · est. 2023 · London, United Kingdom
Innoplexus - a Partex Company is the older company (2011 vs 2023); Innoplexus - a Partex Company is the larger of the two.
Side-by-Side Comparison
| Metric | Innoplexus - a Partex Company | Sable Bio |
|---|---|---|
| Founded | ||
| Founded | 2011 older | 2023 |
| Headquarters | ||
| Headquarters | Frankfurt, Germany | London, United Kingdom |
| Employees | ||
| Employees | 276 larger | 16 |
| Industry | ||
| Industry | AI, Analytics, Biotechnology | AI, Biotechnology, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Series C | Seed |
| Total Funding | ||
| Total Funding | Not tracked yet | $4.24M |
| Funding Rounds | ||
| Funding Rounds | 4 | 2 |
| Services | ||
| Services | Drug Discovery and Development, Data-Driven Therapeutic Optimization, AI-Enabled Asset Repositioning, Functional Assay Development, Real-World Data Partnerships, AI Model Training and Simulation | AI-driven toxicology analysis platform, Unified safety data management, Risk prioritization and mitigation |
| Target Customers | ||
| Target Customers | Pharmaceutical Companies, Biotechnology Firms, Clinical Research Organizations, Healthcare Providers, Research Institutions | toxicologists, pharmaceutical companies, biotech firms, safety teams |
| Taxonomy | ||
| Taxonomy | AI In Drug Discovery, Blockchain For Life Sciences, Biomedical Data Analysis, Clinical Trial Optimization, Continuous Decision-Making, Data As A Service (DaaS), Continuous Analytics As A Service (CaaS), Pharmaceutical Innovation, Preclinical To Commercial Drug Development, Network Analysis, Natural Language Processing, Entity Normalization, Ontologies | Drug Safety Prediction, Clinical Side Effects Assessment, Drug Development Optimization, Data-Driven Drug Development, AI In Biomedical Data Analysis, Target Safety Insights, Assay Validation Strategies, Risk Minimization In Drug Development, Toxicity Testing, Biopharmaceutical Data Solutions, Advanced Workflows, Healthcare Data Analytics, Biomedical Data Insights, Pharmaceutical Validation |
| Website | ||
| Website | innoplexus.com | sablebio.com |
About Innoplexus - a Partex Company
Innoplexus - a Partex Company is a pioneering force in the intersection of AI technology and life sciences, aimed at transforming drug discovery and development. Founded in 2011, the company has established itself as an expert with a compelling slogan—"The expert in AI technology for drug discovery...
About Sable Bio
Sable Bio, founded in 2023, is a UK-based innovator at the nexus of AI, Biotechnology, and Privacy and Security. The company is committed to transforming drug development with its pioneering approach to predicting drug safety, thereby minimizing trial failures and optimizing patient outcomes. Their...
We will tell you when either one moves
BounceWatch watches Innoplexus - a Partex Company and Sable Bio for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Innoplexus - a Partex... and Sable Bio — by email.
Frequently Asked Questions
Compare Innoplexus - a Partex Company with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Innoplexus - a Partex Company on 15 Jun 2026, and Sable Bio on 28 Jan 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.